The A$5 million facility is part of a broader planned $17m investment by the company into the Shepparton region including cultivation and end-to-end manufacturing of medicinal cannabis products. Cannatrek founder and CEO Tommy Huppert: accreditation a “major milestone” for the business (photo: MCIA) Founder and CEO Tommy Huppert GMP said accreditation was a “major milestone” for the business which will enable it to do more production in-house, give it full control over product quality, and “see more product available to support patients, faster and at a lower cost”.
Source: Cannabiz